Literature DB >> 18775975

Forkhead box-O transcription factor: critical conductors of cancer's fate.

Carl Weidinger1, Kerstin Krause, Antje Klagge, Stefan Karger, Dagmar Fuhrer.   

Abstract

Cells have evolved elaborated mechanisms to coordinate the cellular answer of either survival or apoptosis. Recent concepts of human carcinogenesis have suggested disturbances in these cellular relays as a potential link to cellular dedifferentiation and uncontrolled proliferation. Forkhead box-O transcription factors (FOXOs) play an important role in tumour suppression by regulating the expression of genes involved in stress resistance, DNA damage repair, cell cycle arrest and apoptosis. The specific regulation of FOXO function is tightly controlled by posttranslational modifications such as phosphorylation, acetylation and ubiquitination. Loss of FOXO function has recently been identified in several human cancers. In this review, we will give an overview about recent progress in the understanding of function and regulation of FOXOs, as well as their role in carcinogenesis. Furthermore, we will discuss a potential clinical use of FOXOs by therapeutically restoring their tumour suppressive properties.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775975     DOI: 10.1677/ERC-08-0153

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  18 in total

1.  PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.

Authors:  I-K Kwon; R Wang; M Thangaraju; H Shuang; K Liu; R Dashwood; N Dulin; V Ganapathy; D D Browning
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

2.  Insulin glargine and insulin have identical effects on proliferation and phosphatidylinositol 3-kinase/AKT signalling in rat thyrocytes and human follicular thyroid cancer cells.

Authors:  K Müller; C Weidinger; D Führer
Journal:  Diabetologia       Date:  2010-02-24       Impact factor: 10.122

3.  Sub-circuits of a gene regulatory network control a developmental epithelial-mesenchymal transition.

Authors:  Lindsay R Saunders; David R McClay
Journal:  Development       Date:  2014-03-05       Impact factor: 6.868

4.  FHIT gene expression is repressed by mitogenic signaling through the PI3K/AKT/FOXO pathway.

Authors:  Kevin Kelley; Steven J Berberich
Journal:  Am J Cancer Res       Date:  2011       Impact factor: 6.166

5.  Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.

Authors:  Na Wang; Junjun She; Wei Liu; Jing Shi; Qi Yang; Bingyin Shi; Peng Hou
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a.

Authors:  Wei Qiang; Fang Sui; Jingjing Ma; Xinru Li; Xiaojuan Ren; Yuan Shao; Jiazhe Liu; Haixia Guan; Bingyin Shi; Peng Hou
Journal:  Endocrine       Date:  2017-02-20       Impact factor: 3.633

7.  SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway.

Authors:  Gui'e Xie; Xun Zhu; Qing Li; Minghui Gu; Zhenjian He; Jueheng Wu; Jun Li; Yongcheng Lin; Mengfeng Li; Zhigang She; Jie Yuan
Journal:  Br J Pharmacol       Date:  2010-01-28       Impact factor: 8.739

8.  Serum miR-182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats.

Authors:  Merricka C Livingstone; Natalie M Johnson; Bill D Roebuck; Thomas W Kensler; John D Groopman
Journal:  Mol Carcinog       Date:  2019-08-02       Impact factor: 4.784

9.  KRIT1 regulates the homeostasis of intracellular reactive oxygen species.

Authors:  Luca Goitre; Fiorella Balzac; Simona Degani; Paolo Degan; Saverio Marchi; Paolo Pinton; Saverio Francesco Retta
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

10.  Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal.

Authors:  Magdalena Chechlinska; Jan Konrad Siwicki; Monika Gos; Malgorzata Oczko-Wojciechowska; Michal Jarzab; Aleksandra Pfeifer; Barbara Jarzab; Jan Steffen
Journal:  BMC Genomics       Date:  2009-06-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.